Acting on both GIP and GLP-1 receptors, tirzepatide is compounded as a sterile injectable solution. It supports blood glucose regulation and is commonly formulated for weight management, working to help reduce appetite and slow gastric emptying alongside a reduced-calorie diet and increased physical activity.
Compounding required for medical necessity.

Download a compounding order form for this medication with dose options and packaging choices.